Methadone maintenance treatment is a chronic treatment for opiate addicts. After having reached full capacity, new admissions to our clinic were delayed (through a waiting list) for all but opiate addicts with HIV and pregnant women. We compared characteristics and outcomes between patients admitted without delay (1993–2002) and those admitted through a waiting list (2003–2009). All 704 patients admitted between June 1993 and June 2009 were followed up until June 2010. There were 470 patients in the early period and 234 in the late period (56 patients were admitted immediately and 178 after 1.1 ± 0.8 years of waiting). Predictors for 1-year retention in treatment (logistic regression model) were if a patient self-referred during the late period, on a waiting list. The waiting list patient group was characterized by older age and self-referral – two known independent predictors of better retention that were attributed to their superior retention rate.

Dole VP, Nyswander ME, Kreek MJ: Narcotic blockade – a medical technique for stopping heroin use by addicts. Trans Assoc Am Physicians 1966;79:122–136.
NIH Consensus Statement 1997;15:1–38.
McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP: The effects of psychosocial services in substance abuse treatment. JAMA 1993;269:1953–1959.
Appel PW, Ellison AA, Jansky HK, Oldak R: Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse 2004;30:129–153.
Farabee D, Leukefeld CG, Hays L: Accessing drug-abuse treatment: perceptions of out of treatment injectors. J Drug Issues 1998;28:381–394.
Rotstein DL, Alter DA: Where does the waiting list begin? A short review of the dynamics and organization of modern waiting lists. Soc Sci Med 2006;62:3157–3160.
Bell J, Caplehorn JRM, McNeil DR: The effect of intake procedures on performance in methadone maintenance. Addiction 1994;89:463–471.
Claus RE, Kindleberger LR: Engaging substance abusers after centralized assessment: predictors of treatment entry and dropout. J Psychoactive Drugs 2002;34:25–31.
Addenbrooke WM, Rathod NH: Relationship between waiting time and retention in treatment amongst substance abusers. Drug Alcohol Depend 1990;26:255–264.
Best D, Noble A, Ridge G, Gossop M, Farrell M, Strang J: The relative impact of waiting time and treatment entry on drug and alcohol abuse. Addict Biol 2002;7:67–74.
Stark MJ, Campbell BK, Brinkerhoff CV: ‘Hello, may we help you?’ A study of attrition prevention at the time of the first phone contact with substance-abusing clients. Am J Drug Alcohol Abuse 1990;16:67–76.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, ed 4 text rev. Washington, APA, 2000.
McLellan AT, Luborsky L, O’Brien CP, Barr HL, Evans F: The Addiction Severity Index in three different populations. NIDA Res Monogr 1984;55:217–223.
Hawks RL: Analytical methodology. NIDA Res Monogr 1986;73:30–42.
Hosmer DW, Lemeshow S: A goodness-of-fit test for multiple regression model. Comm Stat 1980;A10:1043–1069.
Peles E, Schreiber S, Adelson M: Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment clinic in Israel. Drug Alcohol Depend 2006;82:211–217.
Peles E, Schreiber S, Adelson M: 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment center in Israel. Drug Alcohol Depend 2010;107:141–148.
Corsi KF, Kwiatkowski CF, Booth RE: Treatment entry and predictors among opiate-using injection drug users. Am J Drug Alcohol Abuse 2007;33:121–127.
Haasen C, Prinzleve M, Zurhold H, Rehm J, Güttinger F, Fischer G, Jagsch R, Olsson B, Ekendahl M, Verster A, Camposeragna A, Pezous AM, Gossop M, Manning V, Cox G, Ryder N, Gerevich J, Bacskai E, Casas M, Matali JL, Krausz M: Cocaine use in Europe – a multi-centre study. Methodology and prevalence estimates. Eur Addict Res 2004;10:139–146.
Miech RA, Chilcoat H, Harder VS: The increase in the association of education and cocaine use over the 1980s and 1990s: evidence for a ‘historical period’ effect. Drug Alcohol Depend 2005;79:311–320.
Israel Anti-Drug Authority: Seventh National Epidemiological Survey 2009.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.